Labcorp Holdings (LH) Cash from Investing Activities (2009 - 2026)
Labcorp Holdings (LH) posted Cash from Investing Activities of -$322.1 million for Q1 2026, up 17.39% sequentially from -$389.9 million in Q4 2025, and up 4.14% YoY from -$309.3 million in Q1 2025.
Labcorp Holdings (LH) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Labcorp Holdings has reported Cash from Investing Activities for 18 years, with the latest figure at -$322.1 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 4.14% year-over-year to -$322.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (up 9.9% YoY) and the FY2025 annual result came in at -$1.2 billion, up 12.64% from the prior year.
- Cash from Investing Activities grew to -$322.1 million in Q1 2026 per LH's latest filing, from -$389.9 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$94.1 million in Q2 2025 and troughed at -$579.1 million in Q3 2024.
- A 5-year average of -$335.7 million and a median of -$330.6 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities plunged 332.85% in 2022, then surged 82.6% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$273.3 million in 2022, then dropped by 20.97% to -$330.6 million in 2023, then surged by 36.6% to -$209.6 million in 2024, then tumbled by 86.02% to -$389.9 million in 2025, then increased by 17.39% to -$322.1 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$322.1 million, -$389.9 million, and -$374.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | -322.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -322.10 Mn |
| Mar 31, 2026 | -322.10 Mn |
| Dec 31, 2025 | -389.90 Mn |
| Dec 31, 2025 | -389.90 Mn |
| Sep 30, 2025 | -374.00 Mn |
| Sep 30, 2025 | -374.00 Mn |
| Jun 30, 2025 | -94.10 Mn |
| Jun 30, 2025 | -94.10 Mn |
| Mar 31, 2025 | -336.00 Mn |
| Mar 31, 2025 | -336.00 Mn |
| Dec 31, 2024 | -209.60 Mn |
| Dec 31, 2024 | -209.60 Mn |
| Sep 30, 2024 | -579.10 Mn |
| Sep 30, 2024 | -579.10 Mn |
| Jun 30, 2024 | -185.00 Mn |
| Jun 30, 2024 | -185.00 Mn |
| Mar 31, 2024 | -393.10 Mn |
| Mar 31, 2024 | -393.10 Mn |
| Dec 31, 2023 | -330.60 Mn |
| Dec 31, 2023 | -330.60 Mn |